MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+0.4%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$549M
AUM Growth
+$549M
(-15%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-3.52%
Top 10 Holdings %
Top 10 Hldgs %
73.13%
Holding
35
New
2
Increased
2
Reduced
22
Closed
2
Top Buys
| 1 |
MEI Pharma
MEIP
|
$33M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$2.92M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$2.31M |
| 4 |
Verastem
VSTM
|
$916K |
Top Sells
| 1 |
iTeos Therapeutics
ITOS
|
$12.2M |
| 2 |
LHDX
Lucira Health, Inc. Common Stock
LHDX
|
$4.39M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$1.37M |
| 4 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$824K |
| 5 |
Cytokinetics
CYTK
|
$685K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cullinan Oncology
CGEM
$445M
| $118M | 21.51% | 7,648,268 | – | – |
|
|
2
iTeos Therapeutics
ITOS
| $85.9M | 15.66% | 1,844,727 -262,365 | -12% | -$12.2M |
|
3
Repare Therapeutics
RPTX
$71.7M
| $34.6M | 6.3% | 1,639,849 | – | – |
|
|
4
MEI Pharma
MEIP
$160M
| $33M | 6.01% | +12,350,971 | New | +$33M |
|
5
Merus
MRUS
$4.98B
| $29.5M | 5.38% | 927,302 -14,646 | -2% | -$466K |
|
6
Werewolf Therapeutics
HOWL
$59.9M
| $28.4M | 5.19% | 2,388,011 | – | – |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $24.1M | 4.4% | 3,196,707 | – | – |
|
8
Intellia Therapeutics
NTLA
$1.22B
| $19M | 3.46% | 160,527 -2,093 | -1% | -$247K |
|
|
TCRR
9
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $15.7M | 2.86% | 3,370,982 | – | – |
|
|
TPTX
10
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $12.9M | 2.36% | 271,350 | – | – |
|
|
ONCR
11
DELISTED
Oncorus, Inc.
ONCR
| $12.5M | 2.28% | 2,377,031 | – | – |
|
|
12
Crinetics Pharmaceuticals
CRNX
$2.92B
| $10.8M | 1.97% | 379,792 +81,400 | +27% | +$2.31M |
|
|
13
Cytokinetics
CYTK
$4.23B
| $10.6M | 1.93% | 232,268 -15,023 | -6% | -$685K |
|
14
ESSA Pharma
EPIX
$11.4M
| $9.5M | 1.73% | 668,688 -14,599 | -2% | -$207K |
|
15
BioCryst Pharmaceuticals
BCRX
$1.74B
| $9.17M | 1.67% | 661,951 -42,816 | -6% | -$593K |
|
16
Travere Therapeutics
TVTX
$1.56B
| $8.94M | 1.63% | 287,893 -18,622 | -6% | -$578K |
|
|
GTHX
17
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $8.75M | 1.59% | 856,798 -3,704 | -0.4% | -$37.8K |
|
|
EPZM
18
DELISTED
Epizyme, Inc
EPZM
| $8.56M | 1.56% | 3,425,202 -547,628 | -14% | -$1.37M |
|
19
Y-mAbs Therapeutics
YMAB
$388M
| $7.24M | 1.32% | 446,457 -6,513 | -1% | -$106K |
|
20
Geron
GERN
$893M
| $6.86M | 1.25% | 5,623,889 -108,881 | -2% | -$133K |
|
21
ADC Therapeutics
ADCT
$345M
| $6.82M | 1.24% | 337,396 -7,123 | -2% | -$144K |
|
|
22
Verastem
VSTM
$569M
| $6.71M | 1.22% | 3,271,532 +446,675 | +16% | +$916K |
|
23
Harmony Biosciences
HRMY
$2.12B
| $6.07M | 1.11% | 142,437 -9,213 | -6% | -$393K |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $5.93M | 1.08% | 513,333 -33,225 | -6% | -$384K |
|
25
NeoGenomics
NEO
$1.13B
| $4.79M | 0.87% | 140,422 -9,082 | -6% | -$310K |
|